These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292 [TBL] [Abstract][Full Text] [Related]
29. Combination therapy using the small interfering RNA bevasiranib. Singerman L Retina; 2009 Jun; 29(6 Suppl):S49-50. PubMed ID: 19553802 [TBL] [Abstract][Full Text] [Related]
30. Opportunities and challenges in the development of combination therapy for the treatment of retinal diseases. Hohman TC Retina; 2009 Jun; 29(6 Suppl):S51-3. PubMed ID: 19553804 [TBL] [Abstract][Full Text] [Related]
31. Complement Factor P in choroidal neovascular membranes of patients with age-related macular degeneration. Wolf-Schnurrbusch UE; Stuck AK; Hess R; Wolf S; Enzmann V Retina; 2009; 29(7):966-73. PubMed ID: 19584655 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration. Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484 [TBL] [Abstract][Full Text] [Related]
33. Age-related macular degeneration: a leading cause of blindness. Yuile PG; Chin RM; Izard MA Med J Aust; 1997 Mar; 166(6):331. PubMed ID: 9087193 [No Abstract] [Full Text] [Related]